ADAP - Adaptimmune Therapeutics plc (ADAP) Q1 2024 Earnings Call Transcript
2024-05-15 10:07:03 ET
Adaptimmune Therapeutics plc (ADAP)
Q1 2024 Earnings Conference Call
May 15, 2024, 08:00 AM ET
Company Participants
Juli Miller - Investor Relations
Adrian Rawcliffe - Chief Executive Officer
Gavin Wood - Chief Financial Officer
Dennis Williams - Head of Late Stage Development
Cintia Piccina - Chief Commercial Officer
John Lunger - Chief Patient Supply Officer
Elliot Norry - Chief Medical Officer
Conference Call Participants
Jonathan Chang - Leerink Partners
Marc Frahm - TD Cowen
Tony Butler - Rodman & Renshaw
Graig Suvannavejh - Mizuho Securities
Arthur He - H.C. Wainwright
Peter Lawson - Barclays
Presentation
Operator
Good morning, ladies and gentlemen, and welcome to the Adaptimmune Q1 2024 Financial and Business Update Conference Call.
I would now like to turn the meeting over to Ms. Juli Miller. Please go ahead, Ms. Miller.
Juli Miller
Good morning, and welcome to our conference call to discuss our first quarter 2024 financial results and business updates....
Adaptimmune Therapeutics plc (ADAP) Q1 2024 Earnings Call Transcript